Cytodyn Inc (CYDY)

[IndexGuy]

Saltz- that's been my argument as well,and I've been on record as saying we'll never even go to P3 for m/m or conduct a long hauler trial because we simply don't have the time and resources in an ultra competitive landscape.

I'm quite positive based on EIND that we will show efficacy, but I'm terrified it won't be enough to halt the trial. If we're enrolling 1 per day, we'll be into 2021, and there will quite likely be others who establish themselves, even if they don't work as well. That's where I see a disconnect with the science and the business risk. We need that money to move the rest of the company forward.